Patent ID: 11884725
Assignee: AMPSOURCE BIOPHARMA SHANGHAI INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 15:
16. The pharmaceutical composition according to claim 14, wherein the pharmaceutical composition further comprises an additional pharmaceutically active agent;
wherein the additional pharmaceutically active agent is a medicament with anti-tumor activity, wherein the tumor is selected from lung cancer, squamous cell lung cancer, melanoma, renal cancer, breast cancer, IM-TN breast cancer, colorectal cancer, leukemia or a metastatic lesion of the cancer; or
the additional pharmaceutically active agent is a medicament for treating an infectious disease, wherein the infectious disease is selected from viral infection, bacterial infection, fungal infection and parasitic infection, including but not limited to, HIV, hepatitis virus, herpes virus or sepsis; or
the additional pharmaceutically active agent is a medicament for treating autoimmune diseases, wherein the autoimmune disease is selected from rheumatoid arthritis, psoriasis, systemic lupus erythematosus, primary biliary cirrhosis, autoimmune hemolytic anemia, autoimmune thrombocytopenic purpura, insulin-dependent diabetes mellitus, Graves' disease, myasthenia gravis, autoimmune hepatitis and multiple sclerosis.